SCHEMBL715815

SCHEMBL715815

CCCC(O)c1nc(Cl)c2ncn(C)c2n1

nearest known ligand 0.43

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ADORA2A P29274 1/20 0.43
ADORA1 P30542 1/20 0.43
CDK1 P06493 7/20 0.40
YTHDC1 Q96MU7 1/20 0.38
CCNE1 P24864 3/20 0.33
CDK2 P24941 3/20 0.33
CCNB1 P14635 2/20 0.33
CCNE2 O96020 2/20 0.32
TP53 P04637 1/20 0.32
KDM4E B2RXH2 1/20 0.32
CCNB2 O95067 1/20 0.32
ALDH1A1 P00352 1/20 0.32
CYP1A2 P05177 1/20 0.32
CYP3A4 P08684 1/20 0.32
GAA P10253 1/20 0.32
CYP2D6 P10635 1/20 0.32
MAPT P10636 1/20 0.32
ALOX15 P16050 1/20 0.32
NFKB1 P19838 1/20 0.32
CCNA2 P20248 1/20 0.32

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL716305 0.83 ADORA2A (0.57) ADORA2AADORA1CDK1CCNE1CDK2
SCHEMBL7292026 0.71 CDK1 (0.47) ADORA2AADORA1CDK1YTHDC1CCNE1
SCHEMBL29426225 0.70 CDK1 (0.68) ADORA2AADORA1CDK1YTHDC1CCNE1
SCHEMBL183035 0.70 CDK1 (0.68) ADORA2AADORA1CDK1YTHDC1CCNE1
SCHEMBL21268647 0.69 CDK1 (0.42) CDK1YTHDC1KDM4EALDH1A1GAA
SCHEMBL29388434 0.69 CDK1 (0.42) CDK1YTHDC1KDM4EALDH1A1GAA
SCHEMBL21282860 0.68 CDK1 (0.44) ADORA2AADORA1CDK1YTHDC1CCNE1
SCHEMBL4378141 0.67 CDK1 (0.50) ADORA2AADORA1CDK1YTHDC1CCNE1
SCHEMBL380974 0.67 CDK1 (0.50) ADORA2AADORA1CDK1YTHDC1CCNE1
SCHEMBL764036 0.67 CDK1 (0.59) ADORA2AADORA1CDK1YTHDC1CCNE1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20160002244-A1 OXIDATED DERIVATIVES OF TRIAZOLYLPURINES USEFUL AS LIGANDS OF THE ADENOSINE A2A RECEPTOR AND THEIR USE AS MEDICAMENTS SIGMA-TAU INDUSTRIE FARMACEUTICHE RIUNITE S.P.A. (IT) 2016-01-07 US disclosed
US-9133197-B2 Oxidated derivatives of triazolylpurines useful as ligands of the adenosine A2A receptor and their use as medicaments SIGMA-TAU INDUSTRIE FARMACEUTICHE RIUNITE S.P.A. (IT) 2015-09-15 US disclosed
EP-2408775-B1 OXIDATED DERIVATIVES OF TRIAZOLYLPURINES USEFUL AS LIGANDS OF THE ADENOSINE A2A RECEPTOR AND THEIR USE AS MEDICAMENTS SIGMA TAU IND FARMACEUTI (IT) 2015-06-17 EP disclosed
US-20120053191-A1 OXIDATED DERIVATIVES OF TRIAZOLYLPURINES USEFUL AS LIGANDS OF THE ADENOSINE A2A RECEPTOR AND THEIR USE AS MEDICAMENTS ALFASIGMA S.P.A. (IT) 2012-03-01 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20120053191-A1 OXIDATED DERIVATIVES OF TRIAZOLYLPURINES USEFUL AS LIGANDS OF THE ADENOSINE A2A RECEPTOR AND THEIR USE AS MEDICAMENTS ADORA2A, ADORA3, ADORA1 ADORA2A 1/4885ADORA1 3/4885CDK1 720/4885
US-20160002244-A1 OXIDATED DERIVATIVES OF TRIAZOLYLPURINES USEFUL AS LIGANDS OF THE ADENOSINE A2A RECEPTOR AND THEIR USE AS MEDICAMENTS ADORA2A, ADORA3, ADORA1 ADORA2A 1/4885ADORA1 3/4885CDK1 720/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.